Skip to main content

In memory of Aurora

This past week we lost a major figure in the HPS community, Aurora (pictured here in the middle). Aurora attended her first HPS conference last year. She did more for the HPS community than I think she ever knew. She was such a source of hope to so many, especially the younger people with HPS. Aurora passed away at 74 years of age.

It's never easy to lose someone, no matter how old they are. But to a community of people that often question whether they'll ever reach retirement age, Aurora's story meant a lot.

Aurora didn't speak English and thus her daughter Fran joined the HPS adults listserv. It's a group typically kept to just those with HPS, but Aurora wanted to know what was going on, and so she participated through Fran. Besides, our family listserv right now is mostly parents and we didn't think Fran would find the kind of support she needed there either.

Fran has been such a great addition to our list sharing stories about her mom, keeping us posted on her progress and offering so many words of wisdom and support to everyone. Now Fran couldn't leave us if she wanted to - and I hope will continue to be the voice of loved ones, as well as of her mother, in the HPS community.

Aurora made one last gift to the HPS community. This week she made a final trip to the NIH. There the doctors will be able to study her to better understand the long-term affects of HPS.

Every time an HPS'er and their family make this decision, I can't help but get emotional about it. They are amazing people to be able to think of all of us in the midst of their own grief and pain.

Aurora was such a fighter. She fought HPS so hard. Now, I'm sure she's at peace at last.

Please pray for Fran and the rest of Aurora's family. We love them all.

Comments

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria